Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of imatinib in acute ischaemic stroke
2017-000075-85Phase 3Active
- Sponsor
- Karolinska Institutet
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain infarction comparing Imatinib with Placebo (2 arms). Primary endpoint: Change in modified Rankin Scale at 3 months. Started Apr 2018; status: active.
02
Drugs
03
Conditions
brain infarction
Beyond the preview
Go deeper on 2017-000075-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000075-85.